BioCentury
ARTICLE | Finance

Ebb & Flow

January 2, 2006 8:00 AM UTC

Perlegen is remaining mum on when and if it will test the IPO waters, but there's a clear incentive for the company to join the public space this year. That's because the personalized medicine and reprofiling company will have a guaranteed investor - Pfizer (PFE) - in a 2006 IPO.

Last week, the pharma company invested $50 million in Perlegen and committed to invest up to an additional $25 million "in the event that Perlegen executes an initial public offering within the coming year." ...